BlackRock Group’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $66K | Buy |
466
+25
| +6% | +$3.54K | ﹤0.01% | 2874 |
|
|
2016
Q3 | $64K | Buy |
441
+11
| +3% | +$1.6K | ﹤0.01% | 2868 |
|
|
2016
Q2 | $43K | Sell |
430
-4
| -0.9% | -$400 | ﹤0.01% | 2931 |
|
|
2016
Q1 | $58K | Buy |
434
+225
| +108% | +$30.1K | ﹤0.01% | 2875 |
|
|
2015
Q4 | $41K | Sell |
209
-5
| -2% | -$981 | ﹤0.01% | 2842 |
|
|
2015
Q3 | $34K | Buy |
214
+100
| +88% | +$15.9K | ﹤0.01% | 2895 |
|
|
2015
Q2 | $46K | Buy |
+114
| New | +$46K | ﹤0.01% | 2856 |
|
|
2015
Q1 | – | Sell |
-13,994
| Closed | -$7.86M | – | 2859 |
|
|
2014
Q4 | $7.86M | Sell |
13,994
-1,394
| -9% | -$783K | ﹤0.01% | 1012 |
|
|
2014
Q3 | $8.07M | Sell |
15,388
-46
| -0.3% | -$24.1K | ﹤0.01% | 991 |
|
|
2014
Q2 | $10.8M | Buy |
15,434
+6,366
| +70% | +$4.45M | 0.01% | 917 |
|
|
2014
Q1 | $4.2M | Buy |
9,068
+3,508
| +63% | +$1.63M | ﹤0.01% | 1161 |
|
|
2013
Q4 | $1.91M | Buy |
+5,560
| New | +$1.91M | ﹤0.01% | 1533 |
|